Dr. Falk Pharma GmbH
PolandAll medications by this manufacturer
-
Budenofalk
Form: foam for rectal use
Active substance Dosage budesonide 2 mg/dose; 48 mg/pen ATC: A07EA06
-
Mucofalk o
Form: powder for preparation of oral suspension
Active substance Dosage Plantago ovata seed coat 3.25 g ATC: A06A
-
Salofalk
Form: suspension, rectal
Active substance Dosage mesalazine 4 mg ATC: A07EC02
-
Salofalk
Form: granules, extended release for oral use
Active substance Dosage Mesalazine 1.5 g ATC: A07EC02
-
Salofalk
Form: granules, extended release for oral use
Active substance Dosage Mesalazine 3 g ATC: A07EC02
-
Salofalk
Form: granules, extended release for oral use
Active substance Dosage Mesalazine 1000 mg ATC: A07EC02
-
Salofalk 1 g
Form: suppositories
Active substance Dosage Mesalazine 1000 mg ATC: A07EC02
-
Salofalk 500
Form: tablets, enteric-coated
Active substance Dosage mesalazine 500 mg ATC: A07EC02
-
Salofalk 500
Form: suppositories
Active substance Dosage Mesalazine 500 mg ATC: A07EC02
-
Ursofalk
Form: capsules
Active substance Dosage ursodeoxycholic acid 250 mg ATC: A05AA02
-
Ursofalk
Form: suspension, oral
Active substance Dosage Ursodeoxycholic acid 250 mg/5 ml ATC: A05AA02
-
Ursofalk
Form: tablets, film-coated
Active substance Dosage ursodeoxycholic acid 500 mg ATC: A05AA02